Drug Shortage Prevention Act of 2025
The Drug Shortage Prevention Act of 2025 requires manufacturers of critical drugs - such as life-saving medications for emergencies, surgery, or serious conditions - to notify the federal government about potential supply disruptions. Manufacturers must report planned production halts at least six months in advance or sudden issues like demand spikes within 10 business days, including reasons and expected duration. The bill also mandates twice-yearly reports on drug supply chains, detailing active ingredient sources and suppliers. This aims to improve transparency and prevent shortages affecting patient access to essential medications.
Bill status
in committee
1 of 4 stages cleared
Introduction
Aug 2025
Committee Review
Floor Vote
President
Introduced Aug 1, 2025
Last action Aug 1, 2025
Floor votes
How they voted
No floor votes recorded yet.
Full legislative history
Actions timeline
Total actions
2
Key actions
0
Committee
1
Aug 1, 2025
Committee
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
upper
Aug 1, 2025
Introduced
Introduced in Senate
upper
1 primary · 5 co-sponsors
Sponsors
Ask Maddy
·
AI policy assistant
Ask Maddy about S 2665
Scope: US
Hi! I can help you understand S 2665. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline